Intra-Cellular Therapies submitted an sNDA to the FDA for lumateperone for the treatment of MDD in adults as as adjunctive therapy to antidepressants.
Your daily dose of the clinical news you may have missed.
Approximately 70% of US adults surveyed hope their primary care clinician will ask about their mental health during an appointment, regardless of the presenting issue.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
The FDA warnings were intended to increase physician monitoring for suicidal thoughts and behaviors but have had dramatic unintended consequences.
Findings from a systematic review and meta-analysis showed 1 in 3 youth with chronic pain were diagnosed with anxiety and 1 in 8 were diagnosed with depression.
Your daily dose of the clinical news you may have missed.
A 14% increase in the rates of primary care safety planning within 2 weeks of a negative screening was associated 25% drop in the rate of attempted suicides.
One in 9 primary care encounters involved a mental health condition, according to an analysis of over 350 million primary care visits.